Stocks Comparison
Anheuser-Busch InBev vs CVS HEALTH: revenue, profit, margins and growth compared
Anheuser-Busch InBev brought in $59.3B of revenue in fiscal 2025, CVS HEALTH $402.1B in fiscal 2025. Revenue changed by -0.7% at Anheuser-Busch InBev and +7.8% at CVS HEALTH on the year before, so CVS HEALTH grew faster. Anheuser-Busch InBev kept 11.5% of its revenue as net profit, CVS HEALTH 0.4%. Free cash flow was $11.2B at Anheuser-Busch InBev and $7.8B at CVS HEALTH.
Side by side, latest fiscal year
| BUD | CVS | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $59.3B | $402.1B |
| Revenue growth | -0.7% | +7.8% |
| Net income | $6.8B | $1.8B |
| Net margin | 11.5% | 0.4% |
| Free cash flow | $11.2B | $7.8B |
| Free cash flow margin | 18.9% | 1.9% |
| Earnings per share (diluted) | $3.39 | $1.39 |
| Cash | $11.6B | $8.5B |
| Debt | $73B | $64.6B |
| Price to earnings | n/a | 64.1 |
| Market value | $153.8B | $114B |
| Dividend yield | n/a | 2.98% |
| Rank by revenue in sector | #8 of 125 · Consumer staples | #1 of 125 · Consumer staples |
Over the years
Questions about Anheuser-Busch InBev and CVS HEALTH
Which is bigger by revenue, Anheuser-Busch InBev or CVS HEALTH?
CVS HEALTH is bigger by revenue: $402.1B in fiscal 2025, against $59.3B for Anheuser-Busch InBev in fiscal 2025.
Which keeps more of its revenue as profit, Anheuser-Busch InBev or CVS HEALTH?
Anheuser-Busch InBev had a net margin of 11.5% in fiscal 2025; CVS HEALTH had 0.4% in fiscal 2025.
Which grew revenue faster, Anheuser-Busch InBev or CVS HEALTH?
In their latest fiscal years revenue changed by -0.7% at Anheuser-Busch InBev and +7.8% at CVS HEALTH.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.